nanotech investing Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy
nanotech investing Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of IDH1-Mutant Glioma
nanotech investing Zipalertinib Plus Chemotherapy First-Line Phase 3 REZILIENT3 Trial Data Selected for Presidential Symposium Presentation at the IASLC 2026 World Conference on Lung Cancer
nanotech investing Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment
nanotech investing Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
nanotech investing Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
nanotech investing Satellos Reports Second Quarter 2026 Financial Results and Highlights Company Progress
nanotech investing Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
nanotech investing Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update
nanotech investing Zipalertinib Plus Chemotherapy Meets Primary Endpoint of Progression-Free Survival in Planned Interim Analysis of Phase 3 REZILIENT3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
Edgewater Wireless Reports Fiscal 2026 Year-End Results and Highlights Growing Semiconductor Execution and Industry Validation
Silver Hammer and Stroud Resources Announce Updated Mineral Resource Estimate for the Santo Domingo Silver-Gold Project, Mexico
